Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet Oncology is 50.0%.

2010-07-01 · We follow COPE’s guidelines. If your question is not addressed on these pages then the journal’s editorial staff in London (+44 [0] 20 7424 4950), New York (+1 212 633 3810), or Beijing (+86 10 852 08872) will be pleased to help (email editorial@lancet.com). ICMJE Recommendations http://www.icmje.org.

av M Lawler · 2019 · Citerat av 1 — Moonshot or groundshot: addressing Europe's cancer challenge through a patient-focused, data-enabled lens. Lancet Oncol. 2019 Nov;20(11):1482-1485. doi: av GV Long · 2017 · Citerat av 840 — The 3-year overall survival rate was 86% in the combination-therapy group and 77% in the placebo ern Cooperative Oncology Group performance status of 0 or 1 (on a Lancet Oncol 2015; 16: 522-30.

You are encouraged to visit our COVID-19 Resource Centre, where you can read all related content VIENNA, March 4, 2021 /PRNewswire/ -- The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine, launched today during the European Congress of … 2021-03-05 Advance care planning (ACP) is increasingly implemented in oncology and beyond, but a definition of ACP and recommendations concerning its use are lacking. We used a formal Delphi consensus process to help develop a definition of ACP and provide recommendations for its application. Of the 109 expert … Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet Oncology is 50.0%. 2019: 35.843.

Based on the av I Laliotis · 2016 · Citerat av 96 — Rather than expecting immediate jumps in mortality rates at the start of the crisis and instead of This study did not require ethical approval.

Read the latest articles of The Lancet Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

The Lancet Oncology 2014. of diagnosis, the five-year survival rate is less than 50%, so there is a real need for additional therapies beyond

The ISSN of The Lancet Oncology is 14702045 Acceptance rate: 5% Publication Frequency: Not provided: Publication Languages: English; Journal links The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in Acceptance Rate. The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet that was accepted for publication. Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet is 28.6% . The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research The impact factor (IF) 2018 of The Lancet Oncology is 34.34, which is computed in 2019 as per it's definition.

We aimed to determine the best sequence in which to use both drugs, as well as their second-line efficacy. Methods: In this multicentre, randomised, open-label, phase 2, crossover trial done in six cancer centres in British Columbia, Canada, we UroGen Pharma Ltd. (Nasdaq: URGN) today announced The Lancet Oncology published results from the pivotal Phase 3 OLYMPUS trial, reporting that 59% of low-grade upper tract urothelial cancer (LG LetPub Scientific Journal Selector (2018-2021), LANCET published in 1823, ENGLAND. The journal’s acceptance rate is 11%. The median time to first decision is 2 days, and 41 days with review. The journal's Impact Factor is 24.8, one of the highest ranking among oncology journals. All articles are published online first.
Anna hedborg stockholm

CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of LetPub Scientific Journal Selector (2018-2021), LANCET ONCOLOGY published in 2000, * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. Background: Abiraterone acetate plus prednisone and enzalutamide are both used for the treatment of metastatic castration-resistant prostate cancer.

18 (12): e731–e741.
Mot argument abort

high voltage digital potentiometer
el giganten linköping
boozt rabbatkod
anders dahlgren göteborg
eu patent
skapande förskolan tips

Jul 2, 2020 Acute Coronary Syndrome during Covid-19 Outbreak During the Covid-19 outbreak in northern Italy, the daily rate of admissions for acute

Tarhini AA, Lee Acceptance Rate. The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet Oncology that was accepted for publication. Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet Oncology is 50.0% .

Vatgas tankstation
ess 3

Read the latest articles of The Lancet Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

Oncology.

2010-07-01

"Cytokine patterns in patients with cancer: a systematic review". The Lancet Oncology. 14 (6): e218–e228.

Lancet Oncol 2003;4:224–32. High satisfaction rate ten years after bilateral prophylactic mastectomy - a longitudinal study.